Table 2 Preoperative data on the two patient group
Valuables | Group A (n = 107) | Group B (n = 34) | P value |
|---|---|---|---|
Male, n (%) | 80 (74.8) | 25 (73.5) | 0.885 |
Age,n (year) | 51.6 ± 10.6 | 50.6 ± 11.9 | 0.660 |
BMI (Kg/Mˆ2) | 25.8 ± 3.9 | 25.6 ± 4.2 | 0.754 |
IL-6(pg/mL) | 57.8 ± 39.0 | 211.0 ± 153.7 | <0.001 |
D-dimer (ug/mL) | 7.3 ± 6.1 | 16.7 ± 5.8 | <0.001 |
Leukocyte(10ˆ9/L) | 12.3 ± 4.0 | 12.8 ± 4.7 | 0.540 |
Neutrophile granulocyte(10ˆ9/L) | 10.3 ± 3.9 | 10.8 ± 4.3 | 0.553 |
Leukomonocyte (10ˆ9/L) | 1.1 ± 0.5 | 1.1 ± 0.6 | 0.924 |
PT (sec) | 15.7 ± 13.7 | 15.7 ± 4.9 | 0.982 |
Heamoglobin(g/L) | 129.5 ± 23.6 | 126.7 ± 23.3 | 0.553 |
Albumin(g/L) | 37.3 ± 5.4 | 35.4 ± 4.6 | 0.056 |
Troponin-I (ug/L) | 0.3 ± 1.0 | 1.9 ± 6.5 | 0.158 |
NT-ProBNP (pg/mL) | 704.1 ± 1156.7 | 1993.0 ± 6129.2 | 0.231 |
Serum creatinine (umol/L) | 93.1 ± 42.4 | 136.5 ± 127.7 | 0.060 |
Lactic acid (mmol/L) | 2.0 ± 1.3 | 1.6 ± 1.3 | 0.178 |
Alanine aminotransferase (IU/L) | 63.0 ± 169.8 | 166.5 ± 473.0 | 0.219 |
Aspartate aminotransferase (IU/L) | 69.0 ± 226.2 | 190.4 ± 456.3 | 0.145 |
EF (%) | 63.8 ± 7.0 | 62.7 ± 6.2 | 0.371 |
Marfan Syndrome, n (%) | 5 (4.7) | 2 (5.9%) | 0.865 |
Hypertension, n (%) | 79 (73.8) | 30 (88.2) | 0.080 |
Diabetes, n (%) | 9 (8.4) | 1 (2.9) | 0.485 |
Pericardial effusion (Medium or above), n (%) | 5 (4.7) | 4 (11.8) | 0.715 |
MPS, n (%) | 7 (6.5) | 4 (11.8) | 0.534 |
AR (Medium or above), n (%) | 28 (26.2) | 7 (20.6) | 0.512 |
History of cardiac surgery, n (%) | 8 (7.5) | 4 (11.8) | 0.669 |